Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19.

Sharif, Sameer; Rochwerg, Bram

Sharif, Sameer; Rochwerg, Bram.

Sharif S; McMaster University, Hamilton, Ontario, Canada (S.S., B.R.).
Rochwerg B; McMaster University, Hamilton, Ontario, Canada (S.S., B.R.).

Ann Intern Med ; 174(2): JC16, 2021 02.

Article in English | MEDLINE | ID: covidwho-1110694

ABSTRACT

ABSTRACT

SOURCE CITATION Stone JH, Frigault MJ, Serling-Boyd NJ, et al. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. 2020;3832333-44. 33085857.

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19 Drug Treatment; Respiratory Insufficiency/drug therapy; Adult; Aged; Aged, 80 and over; COVID-19/mortality; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Respiratory Insufficiency/mortality; Respiratory Insufficiency/virology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google